tiprankstipranks
Trending News
More News >
Linc AB (SE:LINC)
:LINC

Linc AB (LINC) AI Stock Analysis

Compare
0 Followers

Top Page

SE

Linc AB

(Frankfurt:LINC)

Rating:57Neutral
Price Target:
Linc AB's strong equity position and low leverage provide a solid financial foundation, but volatility in profitability and cash flow generation pose challenges. The technical analysis indicates bearish momentum, while the low P/E ratio suggests the stock is undervalued. The lack of dividend yield and absence of earnings call and corporate events data limit additional insights. Overall, the stock is moderately rated, reflecting the need for stability in financial performance and improved market sentiment.

Linc AB (LINC) vs. iShares MSCI Sweden ETF (EWD)

Linc AB Business Overview & Revenue Model

Company DescriptionLinc AB is a private equity and venture capital firm, specializing in early, mid and late venture investments in pharmaceutical, life-science and med-tech companies, respectively. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million to SEK 250 million, the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment. Linc AB is based in Stockholm, Sweden.private eequity and venture capital firm, specializing in early, mid and late venture investments in pharmaceutical, life-science and med-tech companies, respectively. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million to SEK 250 million, the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment. Linc AB is based in Stockholm, Sweden.
How the Company Makes MoneyLinc AB generates revenue primarily through its investment activities. The company makes money by acquiring equity stakes in promising healthcare companies and later selling these stakes at a profit. The company may also receive dividends from its investments, depending on the profitability of the portfolio companies. Additionally, Linc AB leverages its expertise and network within the healthcare sector to enhance the value of its investments, contributing to potential capital gains. Significant factors contributing to its earnings include the successful identification of high-potential companies and effective portfolio management.

Linc AB Financial Statement Overview

Summary
Linc AB demonstrates a strong equity position and no leverage, providing a stable financial foundation. However, volatility in profitability metrics and inconsistent cash flow generation present challenges. The company needs to focus on stabilizing its profitability and improving cash flow reliability to enhance its financial performance.
Income Statement
45
Neutral
Linc AB shows strong growth in revenue over recent years, with a notable increase from 2023 to 2024. However, profitability metrics present a mixed picture. The gross profit and net profit margins are high for 2024, yet there are inconsistencies with previous years, reflecting volatility. EBIT and EBITDA margins are also strong for 2024, but the historical performance shows periods of negative margins, indicating instability in the company's operational efficiency.
Balance Sheet
80
Positive
The balance sheet for Linc AB is strong with a solid equity base and no debt in 2024. The debt-to-equity ratio is zero, highlighting low financial risk. The equity ratio is high, indicating that the company is well-capitalized. However, previous years show some liabilities, though they remain minimal relative to equity, indicating robust financial health over time.
Cash Flow
35
Negative
Cash flow analysis reveals challenges, with volatility in operating cash flow and free cash flow over recent years. While there is positive free cash flow in 2024, prior years show significant negative cash flows, reflecting instability in cash generation. The operating cash flow to net income ratio suggests inconsistency in converting income into cash, posing risks to liquidity management.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
5.01M1.29B3.65M2.37M4.14M1.31M
Gross Profit
-5.39M1.29B904.00K-2.66M-2.44M-1.19M
EBIT
2.24B1.28B648.65M-898.43M-37.14M970.05M
EBITDA
-815.74M0.00666.10M9.75M-9.67M0.00
Net Income Common Stockholders
244.33M1.30B619.46M-723.34M-30.03M833.18M
Balance SheetCash, Cash Equivalents and Short-Term Investments
519.98M549.66M519.98M600.55M828.69M21.91M
Total Assets
3.53B4.84B3.53B2.91B3.76B2.64B
Total Debt
0.000.004.48M287.00K127.00K255.00K
Net Debt
-519.98M-549.66M-519.98M-600.26M-828.57M-21.65M
Total Liabilities
2.92M8.76M2.92M2.85M130.48M144.17M
Stockholders Equity
3.53B4.83B3.53B2.91B3.63B2.49B
Cash FlowFree Cash Flow
157.37M29.68M-80.57M-228.15M-353.84M-14.63M
Operating Cash Flow
157.37M29.68M-80.57M-228.15M-353.84M-14.63M
Investing Cash Flow
1.09B0.000.00-199.75M-339.45M-6.38M
Financing Cash Flow
-19.33M0.000.00-5.00M1.16B-7.65M

Linc AB Technical Analysis

Technical Analysis Sentiment
Positive
Last Price71.70
Price Trends
50DMA
67.23
Positive
100DMA
71.49
Positive
200DMA
77.31
Negative
Market Momentum
MACD
0.76
Negative
RSI
60.28
Neutral
STOCH
84.86
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:LINC, the sentiment is Positive. The current price of 71.7 is above the 20-day moving average (MA) of 69.39, above the 50-day MA of 67.23, and below the 200-day MA of 77.31, indicating a neutral trend. The MACD of 0.76 indicates Negative momentum. The RSI at 60.28 is Neutral, neither overbought nor oversold. The STOCH value of 84.86 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:LINC.

Linc AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
kr6.61B32.4716.42%10.18%-1.08%
70
Neutral
€21.65B186.640.27%0.91%13.61%-97.82%
69
Neutral
€4.03B102.167.13%0.28%2.42%20.90%
64
Neutral
$12.85B9.817.59%16985.65%12.30%-7.71%
64
Neutral
€6.23B14.167.27%2.80%
57
Neutral
kr4.15B16.995.76%37.32%-39.07%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:LINC
Linc AB
71.70
-18.40
-20.42%
SE:BURE
Bure Equity AB
292.00
-75.57
-20.56%
SE:IDUN.B
Idun Industrier AB Class B
350.00
132.59
60.99%
SE:MCAP
MedCap AB
441.00
-116.00
-20.83%
SE:SVOL.B
Svolder AB Class B
59.75
-4.59
-7.13%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.